These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36014083)

  • 1. SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV.
    Nomah DK; Llibre JM; Díaz Y; Moreno S; Aceiton J; Bruguera A; Gutiérrez-Macià M; Imaz A; Suanzes P; Navarro G; Orti A; Miro JM; Casabona J; Reyes-Urueña J; The Piscis Study Group
    Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36014083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
    Hensley KS; Jongkees MJ; Geers D; GeurtsvanKessel CH; Mueller YM; Dalm VASH; Papageorgiou G; Steggink H; Gorska A; Bogers S; den Hollander JG; Bierman WFW; Gelinck LBS; Schippers EF; Ammerlaan HSM; van der Valk M; van Vonderen MGA; Delsing CE; Gisolf EH; Bruns AHW; Lauw FN; Berrevoets MAH; Sigaloff KCE; Soetekouw R; Branger J; de Mast Q; Lammers AJJ; Lowe SH; de Vries RD; Katsikis PD; Rijnders BJA; Brinkman K; Roukens AHE; Rokx C
    PLoS Med; 2022 Oct; 19(10):e1003979. PubMed ID: 36301821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV.
    Liu WD; Pang MW; Wang JT; Sun HY; Huang YS; Lin KY; Wu UI; Li GC; Liu WC; Su YC; He PC; Lin CY; Yeh CY; Cheng YC; Yao Y; Chen YT; Wu PY; Chen LY; Luo YZ; Chang HY; Sheng WH; Hsieh SM; Chang SY; Hung CC; Chang SC
    J Virus Erad; 2022 Dec; 8(4):100308. PubMed ID: 36531082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV.
    Corma-Gómez A; Fernández-Fuertes M; García E; Fuentes-López A; Gómez-Ayerbe C; Rivero-Juárez A; Domínguez C; Santos M; Viñuela L; Palacios R; Real LM; Rivero A; Macías J; Pineda JA; García F
    Clin Microbiol Infect; 2022 Nov; 28(11):1492-1498. PubMed ID: 35640840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
    Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
    Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count.
    Antinori A; Cicalini S; Meschi S; Bordoni V; Lorenzini P; Vergori A; Lanini S; De Pascale L; Matusali G; Mariotti D; Cozzi Lepri A; Gallì P; Pinnetti C; Gagliardini R; Mazzotta V; Mastrorosa I; Grisetti S; Colavita F; Cimini E; Grilli E; Bellagamba R; Lapa D; Sacchi A; Marani A; Cerini C; Candela C; Fusto M; Puro V; Castilletti C; Agrati C; Girardi E; Vaia F;
    Clin Infect Dis; 2022 Aug; 75(1):e552-e563. PubMed ID: 35366316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China.
    Wu S; Ming F; Xing Z; Zhang Z; Zhu S; Guo W; Zou S; Liu J; Liu Y; Liang K
    Front Public Health; 2022; 10():883453. PubMed ID: 35615040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV).
    Khan K; Lustig G; Bernstein M; Archary D; Cele S; Karim F; Smith M; Ganga Y; Jule Z; Reedoy K; Miya Y; Mthabela N; Magula NP; Lessells R; de Oliveira T; Gosnell BI; Abdool Karim S; Garrett N; Hanekom W; Bekker LG; Gray G; Blackburn JM; Moosa MS; Sigal A;
    Clin Infect Dis; 2022 Aug; 75(1):e857-e864. PubMed ID: 34893824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey.
    Su J; Jia Z; Wang X; Qin F; Chen R; Wu Y; Lu B; Lan C; Qin T; Liao Y; Shi M; Liao Y; Pan P; Ye L; Jiang J; Liang H
    BMC Infect Dis; 2022 May; 22(1):471. PubMed ID: 35578187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infection and Vaccination Coverage among Fragile Populations in a Local Health Area of Northern Italy.
    Maifredi G; Izzo I; Gasparotti C; Sileo CV; Hiv-CoV Group ; Castelli F; Quiros-Roldan E
    Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV.
    Tuan JJ; Zapata H; Critch-Gilfillan T; Ryall L; Turcotte B; Mutic S; Andrews L; Roh ME; Friedland G; Barakat L; Ogbuagu O
    HIV Med; 2022 Feb; 23(2):178-185. PubMed ID: 34632695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi.
    Mseka UL; Mandolo J; Nyoni K; Divala O; Kambalame D; Mapemba D; Kamzati M; Chibwe I; Henrion MYR; Manda K; Thindwa D; Mvula M; Odala B; Kamng'ona R; Dzinza N; Jere KC; Feasey N; Ho A; Amoah AS; Gordon M; Swarthout TD; Crampin A; Heyderman RS; Kagoli M; Chitsa-Banda E; Mitambo C; Phuka J; Chilima B; Kasambara W; Jambo KC; Chauma-Mwale A
    EClinicalMedicine; 2023 Feb; 56():101800. PubMed ID: 36600885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV.
    Wu S; Zou S; Ming F; Wu M; Guo W; Xing Z; Zhang Z; Liu J; Tang W; Liang K
    BMC Infect Dis; 2023 Jan; 23(1):34. PubMed ID: 36670363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study).
    Kling KD; Janulis P; Demonbreun AR; Sancilio A; Berzins B; Krueger K; Achenbach C; Price R; Sullivan M; Caputo M; Hockney S; Zembower T; McDade TW; Taiwo B
    Front Immunol; 2022; 13():1048776. PubMed ID: 36700200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
    D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral Immune Response to Inactivated COVID-19 Vaccination at the 3rd Month among People Living with HIV.
    Wu S; Zou S; Ming F; Wu M; Guo W; Xing Z; Zhang Z; Liu J; Tang W; Liang K
    Res Sq; 2022 Jun; ():. PubMed ID: 35794897
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 immunity and vaccine strategies in people with HIV.
    Mullender C; da Costa KAS; Alrubayyi A; Pett SL; Peppa D
    Oxf Open Immunol; 2022; 3(1):iqac005. PubMed ID: 36846557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of SARS-CoV-2 Infection Among People Living With HIV in Wuhan, China.
    Wu M; Ming F; Wu S; Liu Y; Zhang X; Guo W; Marley G; Tang W; Liang K
    Front Public Health; 2022; 10():833783. PubMed ID: 35570882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based assessment of SARS-CoV-2 infection among people living with HIV and the general population of Catalonia (March-December, 2020).
    Nomah DK; Díaz Y; Vivanco-Hidalgo RM; Casabona J; Miro JM; Reyes-Urueña J;
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 May; 41(5):294-297. PubMed ID: 37076329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.